Altria has filed a lawsuit against the FDA, alleging the agency has failed to meet the statutory 180-day deadline for reviewing tobacco product applications — and that recent changes to the review system still haven't fixed the problem.

What Altria is claiming

The tobacco giant argues the FDA is blowing past the legal review timeline set by Congress. Under the Tobacco Control Act, the agency is supposed to complete product reviews within 180 days of receiving an application.

Altria says that deadline isn't being met, and that the FDA's recent attempts to overhaul the review process haven't resolved the backlog.

Why this matters for nicotine pouches

The FDA's premarket tobacco product application (PMTA) process covers all new tobacco products — including nicotine pouches. Hundreds of pouch products are currently stuck in review limbo, waiting for authorization that can take years instead of months.

If Altria wins, it could force the FDA to speed up reviews across the board. That would affect not just cigarettes and vapes, but the growing queue of pouch applications from brands trying to enter the U.S. market legally.

The lawsuit also signals mounting frustration from major manufacturers. Altria isn't a small player — it's one of the largest tobacco companies in the U.S., and it's publicly challenging the agency's ability to do its job on time.

What happens next

The case will now move through federal court. Altria hasn't specified what remedy it's seeking, but the lawsuit puts pressure on the FDA to either justify the delays or accelerate the process.

For pouch brands waiting on decisions, this is worth watching. A ruling in Altria's favor could reshape how quickly products get to market — or at least force the FDA to explain why they can't meet their own deadlines.

---

SOURCES:
Tobacco Reporter — https://tobaccoreporter.com/2026/09/02/altria-sues-fda-over-product-review-system/